Gosset Ownership
Private
Therapeutic Areas
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
LookMeds General Information
LookMeds operates as a patient management platform that connects patients with independent physicians and practitioners for access to compounded weight loss medications such as semaglutide and tirzepatide. The company does not develop drugs but facilitates affordable access to these therapies through compounding pharmacy partners. It provides education about the benefits, costs, and regulatory status of compounded GLP-1 agonists for obesity and diabetes[1][2][3][4][8].
Contact Information
Website
Primary Industry
Biomedical IT and Biomedical Data Platforms
Corporate Office
,
United States
United States
Drug Pipeline
semaglutide
CommercialKey Partnerships
LookMeds Funding
No funding data available
To view LookMeds's complete valuation and funding history, request access »